Figure 9.
Plasma hormone levels following administration of TIP39 with or without glutamate receptor blockers. A: Plasma corticosterone. B: Plasma prolactin. Treatment groups as defined in the legend to Figure 8. Significantly different from vehicle-treated animals, *P < 0.0006, #P < 0.01; ANOVA followed by Student-Neuman-Keuls test, n = 4–7/group.